1628 studies found for:    "Perry syndrome" OR "Parkinsonian Disorders"
Show Display Options
Rank Status Study
1 Completed 2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism
Conditions: Progressive Supranuclear Palsy;   Multi-System Atrophy;   Parkinsonism
Intervention: Drug: [F18]-FDDNP
2 Unknown  Measurement of Gait Using Opal APDM and Gait Mat in Parkinsonism
Condition: Parkinsonism
Interventions: Other: GAITRite;   Other: ADPM
3 Terminated
Has Results
Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
Conditions: REM Behavior Disorder;   Parkinsonism
Interventions: Drug: Rozerem;   Drug: Placebo
4 Recruiting Degenerative Nigrostriatal Dysfunction in Drug-induced Parkinsonism
Conditions: Secondary Parkinsonism;   Parkinson's Disease
Intervention: Other: no intervention
5 Enrolling by invitation Effect of Exercise in Parkinsonism
Conditions: Parkinson's Disease;   Drug-induced Parkinsonism
Intervention: Behavioral: Exercise
6 Recruiting 18F-DTBZ PET and Multi-modal MRI in the Patients With Vascular Parkinsonism
Condition: Vascular Parkinsonism
Intervention: Drug: 18F-DTBZ
7 Active, not recruiting Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.
Conditions: Parkinson Disease;   Parkinsonian Disorders
Intervention: Procedure: Biopsy of skin
8 Recruiting Identification, Prevalence, and Lifespan of Rapid-Onset Dystonia-Parkinsonism
Conditions: Dystonia;   Parkinsonism
Intervention:
9 Completed To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism
Condition: Hepatic/Cirrhosis Related Parkinsonism.
Intervention: Drug: Lactulose+Rifaximin +Bromocriptine
10 Active, not recruiting MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.
Conditions: Movement Disorders (Incl Parkinsonism);   Tremor Familial Essential, 1;   REM Sleep Behavior Disorder
Intervention:
11 Enrolling by invitation Non-motor Symptoms and Brain Dopamine Transporter Binding
Conditions: Parkinson Disease;   Parkinsonism
Intervention: Other: DAT SPECT imaging
12 Completed Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath
Conditions: Parkinson's Disease;   Parkinsonism
Intervention: Other: no intervention
13 Unknown  Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
Conditions: Parkinson's Disease;   Parkinsonian Syndrome;   Multiple System Atrophy;   Supranuclear Palsy, Progressive;   Essential Tremor;   Vascular Parkinsonism;   Drug Induced Parkinsonism
Intervention:
14 Recruiting Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)
Conditions: Parkinson Disease;   Neurodegenerative Diseases;   Movement Disorders;   Central Nervous System Diseases;   Brain Diseases;   Basal Ganglia Diseases;   Parkinsonian Disorders
Interventions: Behavioral: Participant self-assessment surveys;   Behavioral: Phonation;   Behavioral: Gait and balance;   Behavioral: Memory;   Behavioral: Dexterity;   Behavioral: Participant open-response writing;   Other: Parkinson mPower mobile application
15 Recruiting Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies
Condition: Parkinsonian Disorders
Interventions: Other: V1: HGPO + meal and V2: placebo + meal;   Other: V1: placebo 75mg + meal and V2: HGPO 75mg + meal
16 Recruiting Repetitive Transcranial Magnetic Stimulation for Freezing of Gait
Condition: Parkinsonian Disorders
Interventions: Device: rTMS Motor cortex;   Device: rTMS Supplementary motor area
17 Completed Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease
Conditions: Parkinson Disease;   Parkinsonian Disorders;   Basal Ganglia Diseases;   Brain Diseases;   Central Nervous System Diseases;   Nervous System Diseases;   Movement Disorders;   Neurodegenerative Diseases
Interventions: Dietary Supplement: Whey protein;   Dietary Supplement: Soy protein
18 Completed Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease;   Movement Disorders;   Parkinsonian Disorders;   Anti-Dyskinesia Agents
Intervention: Drug: AFQ056
19 Completed Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease;   Movement Disorders;   Parkinsonian Disorders;   Anti-Dyskinesia Agents
Interventions: Drug: AFQ056;   Drug: Placebo
20 Completed Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease;   Movement Disorders;   Parkinsonian Disorders
Interventions: Drug: AFQ056;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years